Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

It has been hypothesized that angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) may make patients more susceptible to coronavirus disease 2019 (COVID-19) and to worse outcomes through upregulation of the functional receptor of the virus, angiotensin-converting enz...

Full description

Saved in:

Bibliographic Details
Published in:	JAMA : the journal of the American Medical Association Vol. 324; no. 2; p. 168
Main Authors:	Fosbøl, Emil L, Butt, Jawad H, Østergaard, Lauge, Andersson, Charlotte, Selmer, Christian, Kragholm, Kristian, Schou, Morten, Phelps, Matthew, Gislason, Gunnar H, Gerds, Thomas A, Torp-Pedersen, Christian, Køber, Lars
Format:	Journal Article
Language:	English
Published:	United States 14.07.2020
Subjects:	Adult Aged Angiotensin Receptor Antagonists - administration & dosage Angiotensin-Converting Enzyme Inhibitors - administration & dosage Antihypertensive Agents - therapeutic use Betacoronavirus Case-Control Studies Coronavirus Infections - diagnosis Coronavirus Infections - mortality COVID-19 Denmark Female Humans Hypertension - complications Hypertension - drug therapy Incidence Male Middle Aged Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - mortality Retrospective Studies SARS-CoV-2 Denmark
ISSN:	1538-3598, 1538-3598
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!